A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer

A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer

Background: Colorectal cancer (CRC) is a common malignant tumor that affects the large bowel or the rectum. Cuproptosis, recently discovered programmed cell death process, may play an important role in CRC tumorigenesis. Long non-coding RNAs (lncRNAs) can alter the proliferation of colorectal cancer...

Full description

Bibliographic Details
Main Authors:	Dong Hou, Jia-nan Tan, Sheng-ning Zhou, Xu Yang, Zhi-hong Zhang, Guang-yu Zhong, Lin Zhong, Bin Yang, Fang-hai Han
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Genetics
Subjects:	cuproptosis lncRNA colorectal cancer consistent clustering immune microenvironment tumor mutational burden (TMB)
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.969845/full

Similar Items

Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
by: Zi-Rong Jiang, et al.
Published: (2022-09-01)

Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning
by: Zhixun Bai, et al.
Published: (2022-12-01)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
by: Binfeng Liu, et al.
Published: (2022-10-01)

Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer
by: Hui Chen, et al.
Published: (2023-01-01)

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
by: Mingyi Yang, et al.
Published: (2022-07-01)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
by: Pengpeng Zhang, et al.
Published: (2023-01-01)

Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma
by: Miaorong Xu, et al.
Published: (2022-07-01)

A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer
by: Yuchen Bai, et al.
Published: (2022-11-01)

A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma
by: Jingyi Wu, et al.
Published: (2023-09-01)

Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer
by: Lin Pang, et al.
Published: (2023-03-01)

Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma
by: Tongjin Xie, et al.
Published: (2022-12-01)

Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1
by: Junlin Shen, et al.
Published: (2023-08-01)

Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
by: Liuqing Yang, et al.
Published: (2022-07-01)

Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma
by: Binfeng Liu, et al.
Published: (2022-12-01)

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
by: Yifan Xu, et al.
Published: (2022-10-01)

In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma
by: Yue Wang, et al.
Published: (2022-09-01)

Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia
by: Yidong Zhu, et al.
Published: (2023-02-01)

Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma
by: Xiaojing Yang, et al.
Published: (2022-09-01)

Comprehensive analysis of cuproptosis-related lncRNAs for prognostic significance and immune microenvironment characterization in hepatocellular carcinoma
by: Duguang Li, et al.
Published: (2023-01-01)

Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer
by: Jia Chen, et al.
Published: (2022-12-01)

Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
by: Youlong Huili, et al.
Published: (2022-08-01)

Cuproptosis-associated lncRNAs discern prognosis and immune microenvironment in sarcoma victims
by: Binxiang Chu, et al.
Published: (2022-12-01)

Cuproptosis-related LncRNAs are correlated with immunity and predict prognosis in HNSC independent of TMB
by: Mingyu Li, et al.
Published: (2023-02-01)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma
by: Jun Wen, et al.
Published: (2023-01-01)

Cuproptosis-Related lncRNA Gene Signature Establishes a Prognostic Model of Gastric Adenocarcinoma and Evaluate the Effect of Antineoplastic Drugs
by: Hengjia Tu, et al.
Published: (2022-11-01)

Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma
by: Shusheng Zhu, et al.
Published: (2023-07-01)

Identification and validation of cuproptosis-related LncRNA signatures as a novel prognostic model for head and neck squamous cell cancer
by: Xiajing Liu, et al.
Published: (2022-11-01)

A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma
by: Chao Ma, et al.
Published: (2023-08-01)

Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma
by: Shengxian Xu, et al.
Published: (2022-07-01)

Potential of lncRNAs to regulate cuproptosis in hepatocellular carcinoma: Establishment and validation of a novel risk model
by: Jing He, et al.
Published: (2024-01-01)

A cuproptosis-related lncRNA signature-based prognostic model featuring on metastasis and drug selection strategy for patients with lung adenocarcinoma
by: Mengzhe Zhang, et al.
Published: (2023-09-01)

Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancer
by: Chun Li, et al.
Published: (2023-07-01)

The value of cuproptosis-related differential genes in guiding prognosis and immune status in patients with skin cutaneous melanoma
by: Yuming Sun, et al.
Published: (2023-04-01)

A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer
by: Lei Ren, et al.
Published: (2023-02-01)

Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology
by: Chao Ma, et al.
Published: (2023-02-01)

Development and validation of a cuproptosis-related lncRNA model correlated to the cancer-associated fibroblasts enable the prediction prognosis of patients with osteosarcoma
by: Xiaoping Wang, et al.
Published: (2023-02-01)

A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma
by: Zheng Zhou, et al.
Published: (2023-03-01)

Construction of a prognostic glycolysis‐related lncRNA signature for patients with colorectal cancer
by: Xinyang Zhong, et al.
Published: (2023-01-01)

Prediction of immune infiltration and prognosis for patients with cholangiocarcinoma based on a cuproptosis-related lncRNA signature
by: Hong-Fei Yao, et al.
Published: (2024-01-01)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
by: Chong Li, et al.
Published: (2023-06-01)